✓ Last verified: January 23, 2026 — Edited & verified by Angelica Bottaro for HealingMaps Editorial Staff

Known For: Greenbrook TMS NeuroHealth Centers’ DeBarr Road location is their second Anchorage office, expanding access to FDA-cleared TMS therapy and Spravato (esketamine) in Alaska’s largest city. Part of a national network of over 95 clinics, this location provides the same standardized, evidence-based protocols for treatment-resistant depression and OCD.
| Review Scores | 4.6 stars |
| Location | Anchorage, Alaska |
| Address | 2741 DeBarr Road, Suite 411, Anchorage, AK 99508 |
| Phone | (855) 940-4867 |
| Website | greenbrooktms.com |
| Treatments | TMS Therapy, Spravato (Esketamine) |
| Conditions Treated | Major Depressive Disorder, Treatment-Resistant Depression, OCD |
| Cost | Contact for pricing — insurance often covers TMS |
| Insurance | Most major insurance accepted for TMS |
| KAP Available? | No — Spravato (esketamine nasal spray) available, not IV ketamine |
| Clinical Lead | Greenbrook TMS Clinical Team |
HealingMaps Take: With two Anchorage locations, Greenbrook makes it easier for Alaskans to access TMS and Spravato without long commutes across the city. The DeBarr Road office serves patients on the north and east sides of Anchorage. Greenbrook’s national protocols and insurance acceptance make them one of the more accessible advanced depression treatment options in Alaska.
Market Position: Greenbrook TMS is a verified ketamine provider in the Anchorage metro on HealingMaps — one of 1,473 clinics we have mapped and tracked across 3,142 U.S. counties.
⚠ FDA-cleared indications for TMS therapy: treatment-resistant major depressive disorder (MDD), obsessive-compulsive disorder (OCD, Deep TMS only), anxious depression, short-term smoking cessation, and adolescent MDD (ages 15–21). Use of TMS for other conditions including PTSD, bipolar depression, fibromyalgia, and other indications is off-label — not currently FDA-cleared for those specific indications. Discuss your condition with the clinic to understand insurance coverage and clinical evidence.
Industry pricing reference. Greenbrook TMS has not published specific per-session pricing — contact the clinic directly for a quote. The calculator above shows typical metro-level cost estimates across protocols, not this clinic’s specific prices.
| Protocol | Typical Industry Cost | Offered Here |
|---|---|---|
| IV Ketamine Infusion | $350–$650/session | ✓ |
| Spravato (esketamine) | $0–$250 copay (insured) | ✓ |
| TMS (transcranial magnetic stimulation) | $200–$300/session, often insurance-covered | ✓ |
| IM Ketamine | $250–$400/injection | — |
| KAP (with integrated talk therapy) | $400–$1,200/session | — |
| At-home oral troches | $150–$300/month | — |
Sources: CDC PLACES 2023 (Anchorage County, AK, crude prevalence) · U.S. Census ACS 5 Year · HealingMaps proprietary patient inquiry data.
Behind this data: HealingMaps has analyzed 23,496 patient inquiries (Oct 2022 – Mar 2026), mapped 1,473 verified clinics across 3,142 counties, scraped 132 clinic pricing pages, and collected 658 practitioner survey responses. This snapshot reflects our multi-source methodology.
44.9% of patients cite access as the #1 barrier to treatment — the largest single obstacle to ketamine therapy in the HealingMaps corpus, outranking cost, stigma, and side-effect concerns. Source: HealingMaps 2026 Ketamine Clinic Intelligence Report — drawn from 23,496 patient inquiries and 132 clinic website analyses.
This 2-question summary is matched to the protocols and conditions Greenbrook TMS treats. Editorial responses are HealingMaps-authored, grounded in our 2026 Ketamine Clinic Intelligence Report.
Yes — Greenbrook TMS offers Spravato, which means they’re FDA REMS-certified and maintain the required two-hour in-office monitoring window after each dose. Spravato is the primary insurance-covered ketamine option for treatment-resistant depression. Worth confirming the prior-authorization timeline before booking your first session.
Greenbrook TMS treats depression via Spravato (FDA-cleared for TRD). The Spravato pathway is the most likely to obtain commercial insurance coverage. TRD is typically defined as two or more prior antidepressant trials without sufficient response — patients meeting that bar are best candidates here.
In addition to ketamine and Spravato, this clinic offers TMS therapy — an FDA-cleared, insurance-covered alternative for patients who prefer no IV, no sedation, and no recovery time. A standard course runs 36 sessions over 6 to 9 weeks, with most major commercial plans, Medicare Part B, and Tricare covering treatment after prior authorization. This clinic uses BrainsWay Deep TMS, the only TMS device with standalone FDA clearance for OCD via the H7 coil. Read our complete guide to TMS therapy for FDA-cleared conditions, device differences, insurance coverage by carrier, and what to expect at your first appointment. Browse verified TMS clinics in our directory.
View all REMS-certified Spravato clinics in Alaska and across the United States.
Leave a Reply